Editor’s Note: The home page of the BioNJ website provides an up-to-the-minute headline service where readers can access press releases issued by New Jersey-based biotechnology companies. Go to the “New Jersey Biotechnology Company News” section on the BioNJ home page to read the latest news. Companies wishing to appear in the Biolines Biotechnology Companies in the News section are encouraged to email their news releases to BioNJ.
March 20
ProCure, CentraState Healthcare System and Princeton Radiation Oncology Celebrate Grand Opening of New Jersey and Metro New York’s First Proton Therapy Center
March 19
CorMedix Reports Year End 2011 Financial Results
Advaxis Named to Shortlist for Vaccine Industry Excellence Award
March 16
SK Biopharmaceuticals to Initiate Phase 2 Trials in US
Novartis Acquires Rights to ThromboGenics Eye Drug
March 14
Celldex Announces Exercise of Over-Allotment Option
Unigene Appoints David Moskowitz as Chief Financial Officer
March 8
Steve Carchedi to Join PCAsso Diagnostics’ Strategic Advisory Board
Unigene Announces Fourth Quarter and Full-Year 2011 Results
Celgene Completes Acquisition of Avila Therapeutics
Horizon NJ Health Rates as New Jersey’s Top Medicaid Managed Care Plan
March 7
Celldex Reports Fourth Quarter and Fiscal 2011 Financial Results
Immunomedics Appoints Marcella Locastro to Board of Directors
Pacira Pharmaceuticals, Inc. to Present at Barclays Capital Global Healthcare Conference
Senesco Adds Additional Clinical Site to Evaluate SNS01-T in Multiple Myeloma
SK Bio-Pharmaceuticals Announces New CEO, Dr. Christopher Gallen
NPS Pharmaceuticals to Present at Barclays Capital Global Healthcare Conference
March 6
Aegerion Pharmaceuticals Announces Fourth-Quarter and Full-Year 2011 Financial Results
Paragon to Feature Change Management Solutions for Life Sciences at Model N Rainmaker Conference
Columbia Laboratories Receives Nasdaq Minimum Bid Price Non-compliance Letter
March 5
Merck to Present at the Cowen & Company 32nd Annual Health Care Conference
Aegerion Pharmaceuticals Submits Marketing Applications for Lomitapide in U.S. and EU
Dendreon Announces Webcast Presentation at Upcoming Conferences
March 2
Senesco Announces Additional $1.0 Million Equity Financing
Senesco Adds Second Clinical Site to Evaluate SNS01-T in Multiple Myeloma
Unigene to Announce Fourth Quarter and Full-Year 2011 Financial Results on March 8, 2012
Columbia Laboratories Announces 42% Workforce Reduction
Company Profile for Biomatters Ltd
Amicus Therapeutics Announces Proposed Public Offering of Common Stock
Amicus Therapeutics Prices Underwritten Offering of Common Stock
February 29
NPS Pharmaceuticals Appoints Georges Gemayel, Ph.D., to Board of Directors
Columbia Laboratories Will Present March 5th at Cowen and Company Health Care Conference
Antares Pharma to Present at Upcoming Investor Conferences
U.S. Food and Drug Administration Extends Action Date for ELIQUIS® (apixaban) by Three Months
Celldex Therapeutics to Host Corporate 2011 Year-End and 2012 Objectives Update Call
Aegerion Pharmaceuticals Observes Rare Disease Day 2012
Lexicon Pharmaceuticals to Present at the Cowen and Company 32nd Annual Health Care Conference
Celldex Therapeutics to Host Corporate 2011 Year-End and 2012 Objectives Update Call
TYRX Announces Launch of New Patient Education Web Site HeartDeviceInfection.com
Bristol-Myers Squibb to Present at Cowen and Company Health Care Conference
Amicus Therapeutics to Present at 2012 RBC Global Healthcare Conference
Johnson & Johnson to Participate in Cowen and Company 32nd Annual Health Care Conference
Dendreon Announces Executive Appointments
February 27
NPS Pharmaceuticals Observes Rare Disease Day 2012
Celgene Corporation to Present at Two Upcoming Investor Conferences
Advaxis Low Dose Cohort 1 Meets 50% Efficacy Target In CIN 2/3
Unigene to Present at Ibc’s 4th Annual Asiatides Oligonucleotide and Peptide® Conference
Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2011 Results
February 24
SorinRoyerCooper Named 2012 Life Sciences Law Firm of the Year
Sophion Invites the World to Q2 – a New Dimension in Automated Patch Clamping
Celldex Prices Public Offering of Common Stock
Gilead Sciences to Present at Two Upcoming Investor Conferences
Celldex Therapeutics to Present at the Citi 2012 Global Health Care Conference
February 23
Celldex Announces Public Offering of Common Stock
Lexicon Pharmaceuticals to Present at the RBC Healthcare Conference
Savient Pharmaceuticals to Present at the Cowen and Company 32nd Annual Health Care Conference
The Medicines Company Reports Full Year and Fourth Quarter 2011 Financial Results
February 21
Celgene Corporation to Present at the Citi 2012 Global Health Care Conference
Soligenix Announces Positive Survival Results of SGX202 in Radiation Injury
J&J Announces Retirement of CEO
NPS Pharmaceuticals to Present at Upcoming Conferences
SK Biopharmaceuticals to Initiate Phase 2 Trials in US
February 17
Experts Explain Role of Digital Identities in Transforming Healthcare to Fully Electronic Environment
Catalent Completes Acquisition of Clinical Trials Supplies Business of Aptuit LLC
February 16
Photocure ASA Results for the Fourth Quarter and Full Year 2011
Senesco Technologies Reports Second Quarter Fiscal 2012 Financial Results
Derma Sciences to Present at the LHA Life Sciences & Medtech Virtual Conference on February 16
NPS Pharmaceuticals Reports 2011 Year-End Financial Results and 2012 Cash Burn Guidance